Please…. Stop… save your money#wellness #fyp #weightloss #trend 1. Yakub K, Palikhe S, Iqbal T, et al. Nicotinamide Riboside and Nicotinamide Mononucleotide Facilitate NAD+ Synthesis via Enterohepatic Circulation. Science Advances. 2025. 2. Wakabayashi J, Higashi S, Morifuji M. Sublingual NMN Administration Increases Early Circulating Terminal Metabolites Compared With Oral Administration in Healthy Adult Men. Scientific Reports. 2026. 3. Zhang D, Yau LF, Bai LB, et al. Hydroxyapatite-Based Nano-Drug Delivery System for Nicotinamide Mononucleotide (NMN): Significantly Enhancing NMN Bioavailability and Replenishing In Vivo Nicotinamide Adenine Dinucleotide (NAD+) Levels. International Journal of Pharmaceutics. 2023. 4. Xiao K, Nakagawa T. NAD+ Precursors in Human Health and Disease: Current Status and Future Prospects. Redox Biology. 2023. 5. Kim LJ, Chalmers TJ, Madawala R, et al. Host-Microbiome Interactions in Nicotinamide Mononucleotide (NMN) Deamidation. FEBS Letters. 2023. 6. Ratajczak J, Trammell SAJ, et al. NRK1 Controls Nicotinamide Mononucleotide and Nicotinamide Riboside Metabolism in Mammalian Cells. Nature Communications. 2016. 7. Fletcher RS, Ratajczak J, Doig CL, et al. Nicotinamide Riboside Kinases Display Redundancy in Mediating Nicotinamide Mononucleotide and Nicotinamide Riboside Metabolism in Skeletal Muscle Cells. Molecular Metabolism. 2017. 8. Fan R, Cui J, Ren F, et al. Overexpression of NRK1 Ameliorates Diet- and Age-Induced Hepatic Steatosis and Insulin Resistance. Biochemical and Biophysical Research Communications. 2018. 9. Bounvicino D, Ranieri G, Pittelli M, et al. SIRT1-Dependent Restoration of NAD+ Homeostasis After Increased Extracellular NAD+ Exposure. Journal of Biological Chemistry. 2021. 10. Yoshino J, Baur JA, Imai SI. NAD+ Intermediates: The Biology and Therapeutic Potential of NMN and NR. Cell Metabolism. 2018. 11. Kropotova A, Kulikova V, Solovyeva L, et al. Purine Nucleoside Phosphorylase Controls Nicotinamide Riboside Metabolism in Mammalian Cells. Journal of Biological Chemistry. 2022. 12. Sun JY, Wang ZF, Xu WH, Zhao J. NAD+ Glycohydrolase/CD38 as a Therapeutic Target in Aging: Physiological Roles, Molecular Mechanisms, and Future Opportunities in Anti-Aging Research. Journal of Biochemical Pharmacology. 2025. 13. Tarragó MG, Chini CCS, Kanamori KS, et al. A Potent and Specific CD38 Inhibitor Ameliorates Age-Related Metabolic Dysfunction by Reversing Tissue NAD+ Decline. Cell Metabolism. 2018. 14. Grozio A, Sociali G, Sturla L, et al. CD73 Protein as a Source of Extracellular Precursors for Sustained NAD+ Biosynthesis in FK866-Treated Tumor Cells. Journal of Biological Chemistry. 2013. 15. Escande C, Nin V, Price NL, et al. Flavonoid Apigenin Is an Inhibitor of the NAD+ase CD38: Implications for Cellular NAD+ Metabolism, Protein Acetylation, and Treatment of Metabolic Syndrome. Diabetes. 2013. 16. Deng C, Liu J, Hou M, Deng Y, et al. Double-Prolonged NAD Preservation: Delaying Cellular Senescence and Initiating Musculoskeletal Regeneration. Aging Cell. 2026. 17. Zhang Z, Ansari AJ, Fayne ER, et al. Emerging Medicinal Strategies for CD38 Inhibition: Restoring NAD+ Metabolism and Disease Control. Bioorganic & Medicinal Chemistry. 2026. 18. Sun X, Su L, Bu T, Zhang Y. Exercise Training Upregulates Intracellular Nicotinamide Phosphoribosyltransferase Expression in Humans: A Systematic Review With Meta-Analysis. Frontiers in Public Health. 2023. 19. Costford SR, Bajpeyi S, Pasarica M, et al. Skeletal Muscle NAMPT Is Induced by Exercise in Humans. American Journal of Physiology. 2010. 20. Gallagher C, Emmanuel OO. NAD+ Supplementation for Anti-Aging and Wellness: A PRISMA-Guided Systematic Review of Preclinical and Clinical Evidence. Ageing Research Reviews. 2026. 21. Wei D, Huang Y, Shi D, et al. Structure Guided Engineering of Bifunction Enzyme NadR for Enhanced Nicotinamide Adenine Dinucleotide Production. Biotechnology and Bioengineering. 2026. 22. Manickam R, Tur J, Badole SL, et al. NAMPT Activator P7C3 - @jojoyourboat